Who owns Navidea Biopharmaceuticals Inc?
- Ticker: NAVB
- CUSIP Number: 63937x202
Tip: Access positions for across all investors
Analyze quarterly positions in Navidea Biopharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Navidea Biopharmaceuticals stock
Who bought or sold Navidea Biopharmaceuticals Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Parallel Advisors | 350.00 | $12.985000 | 0% | Mar 2024 |
|
Who sold out of Navidea Biopharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Geode Capital Management | Sep 2023 | 369k | $33k |
| BlackRock | Sep 2023 | 113k | $10k |
| Boothbay Fund Management | Sep 2023 | 40k | $3.6k |
| Northern Trust | Sep 2023 | 39k | $3.5k |
| Baader Bank | Dec 2023 | 11k | $434.767000 |
| Tower Research Capital | Sep 2023 | 8.9k | $804.330000 |
| Morgan Stanley | Sep 2023 | 4.4k | $396.115200 |
| Goss Wealth Management | Sep 2023 | 412.00 | $36.008800 |